Integrated Phenotypic and Genotypic Drug Susceptibility Profiling of Mycobacterium tuberculosis Reveals High Burden of Multidrug Resistance in Northwest Nigeria
Abstract
Tuberculosis (TB) drug resistance remains a major public health challenge in Northwest Nigeria, undermining effective disease control and treatment outcomes. This study aimed to assess the genotypic and phenotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from patients attending TB Reference Centres, with particular focus on first-line, second-line, repurposed, and new anti-TB drugs. A cross-sectional design was employed involving 503 presumptive TB cases. MTB detection and rifampicin resistance were screened using Xpert MTB/RIF Ultra, genotypic resistance was assessed using Line Probe Assay, and phenotypic susceptibility was evaluated through Lowenstein–Jensen culture and MGIT Bactec 960. Associations between conventional drugs, repurposed drugs (levofloxacin, moxifloxacin, and linezolid), and the new drug bedaquiline with multidrug-resistant TB were analyzed using chi-square tests. The results confirmed MTB in 122 patients (24.3%), including 34 rifampicin-resistant cases (28.0%). Genotypic testing showed that 11 isolates (9.0%) were resistant to at least one drug, whereas 111 isolates (90.9%) were pan-susceptible. The prevalence of multidrug-resistant TB was 17.9%, with high susceptibility to levofloxacin (95.9%) and moxifloxacin (97.5%). Chi-square analysis demonstrated statistically significant associations between conventional, repurposed, and new anti-TB drugs and multidrug-resistant TB (p < .001). Discordance between phenotypic and genotypic…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 122 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.